Edges in Network
| Network | GSE5851_egf1520 - GSE5851 - SiGN-BN HC+Bootstrap |
| Network Description | Phase II exploratory pharmacogenomics study of cetuximab monotherapy in patients with advanced metastatic CRC |
| Node | RDH16 |
| Upstream (Parents) |
|---|
| (<<) CBS → RDH16 |
| (<<) CYP4F2 → RDH16 |
| (<<) GOT1 → RDH16 |
| (<<) NNMT → RDH16 |
| (<<) ORM1 → RDH16 |
| (<<) PCK2 → RDH16 |
| (<<) RNASE4 → RDH16 |
| (<<) SAA4 → RDH16 |
| Downstream (Children) |
|---|
| RDH16 → ACTG1 (>>) |
| RDH16 → ADAM17 (>>) |
| RDH16 → BDH1 (>>) |
| RDH16 → CEBPD (>>) |
| RDH16 → CXCL2 (>>) |
| RDH16 → CYP1A1 (>>) |
| RDH16 → CYP1A2 (>>) |
| RDH16 → ENO3 (>>) |
| RDH16 → FGFR2 (>>) |
| RDH16 → FNDC4 (>>) |
| RDH16 → GAD1 (>>) |
| RDH16 → GPX4 (>>) |
| RDH16 → GRB2 (>>) |
| RDH16 → GRHPR (>>) |
| RDH16 → HSD11B1 (>>) |
| RDH16 → HSD17B2 (>>) |
| RDH16 → HYAL1 (>>) |
| RDH16 → INSR (>>) |
| RDH16 → ITGA2 (>>) |
| RDH16 → JHDM1D (>>) |
| RDH16 → LTA4H (>>) |
| RDH16 → MAFF (>>) |
| RDH16 → MT1G (>>) |
| RDH16 → MTSS1 (>>) |
| RDH16 → NGFR (>>) |
| RDH16 → PNPLA3 (>>) |
| RDH16 → RBKS (>>) |
| RDH16 → RXRA (>>) |
| RDH16 → SET (>>) |
| RDH16 → ST3GAL6 (>>) |
